21.02
Schlusskurs vom Vortag:
$21.91
Offen:
$21.67
24-Stunden-Volumen:
9.99M
Relative Volume:
1.34
Marktkapitalisierung:
$16.37B
Einnahmen:
$5.69B
Nettoeinkommen (Verlust:
$-807.11M
KGV:
-24.64
EPS:
-0.8531
Netto-Cashflow:
$-3.55B
1W Leistung:
-11.49%
1M Leistung:
+14.24%
6M Leistung:
-5.57%
1J Leistung:
+167.09%
Xpeng Inc Adr Stock (XPEV) Company Profile
Firmenname
Xpeng Inc Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XPEV mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
XPEV
Xpeng Inc Adr
|
21.02 | 20.84B | 5.69B | -807.11M | -3.55B | -0.8531 |
![]()
TSLA
Tesla Inc
|
333.87 | 1.12T | 92.72B | 6.12B | 5.59B | 1.73 |
![]()
TM
Toyota Motor Corporation Adr
|
194.57 | 258.39B | 323.93B | 28.59B | -602.82M | 21.58 |
![]()
RACE
Ferrari N V
|
477.21 | 85.36B | 7.57B | 1.74B | 1.49B | 9.6881 |
![]()
HMC
Honda Motor Adr
|
33.40 | 45.19B | 144.56B | 4.71B | -2.57B | 2.8926 |
![]()
GM
General Motors Company
|
58.59 | 55.69B | 187.60B | 4.88B | -1.84B | 6.30 |
Xpeng Inc Adr Stock (XPEV) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-18 | Eingeleitet | BNP Paribas Exane | Neutral |
2025-06-17 | Hochstufung | Goldman | Neutral → Buy |
2025-05-21 | Hochstufung | Macquarie | Neutral → Outperform |
2025-03-19 | Herabstufung | Daiwa Securities | Buy → Neutral |
2025-03-19 | Hochstufung | Nomura | Neutral → Buy |
2025-03-10 | Hochstufung | Citigroup | Neutral → Buy |
2025-02-24 | Hochstufung | UBS | Sell → Neutral |
2025-02-07 | Herabstufung | Macquarie | Outperform → Neutral |
2024-12-05 | Herabstufung | UBS | Neutral → Sell |
2024-11-22 | Hochstufung | China Renaissance | Hold → Buy |
2024-11-21 | Herabstufung | Goldman | Buy → Neutral |
2024-09-05 | Hochstufung | JP Morgan | Neutral → Overweight |
2024-08-30 | Hochstufung | Macquarie | Neutral → Outperform |
2024-06-25 | Hochstufung | Citigroup | Sell → Neutral |
2024-05-23 | Hochstufung | Daiwa Securities | Neutral → Buy |
2024-04-15 | Fortgesetzt | Macquarie | Neutral |
2023-08-21 | Hochstufung | BofA Securities | Neutral → Buy |
2023-08-08 | Hochstufung | CLSA | Outperform → Buy |
2023-08-07 | Hochstufung | HSBC Securities | Hold → Buy |
2023-07-31 | Herabstufung | UBS | Buy → Neutral |
2023-07-27 | Hochstufung | Jefferies | Hold → Buy |
2023-07-27 | Hochstufung | Macquarie | Underperform → Outperform |
2023-07-21 | Herabstufung | JP Morgan | Neutral → Underweight |
2023-07-11 | Eingeleitet | Goldman | Buy |
2023-06-30 | Herabstufung | CLSA | Buy → Outperform |
2023-05-25 | Herabstufung | Barclays | Equal Weight → Underweight |
2023-04-25 | Hochstufung | Jefferies | Underperform → Hold |
2023-03-24 | Herabstufung | Bernstein | Outperform → Mkt Perform |
2023-02-24 | Herabstufung | HSBC Securities | Buy → Hold |
2023-01-11 | Herabstufung | JP Morgan | Overweight → Neutral |
2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
2022-12-14 | Herabstufung | Daiwa Securities | Buy → Sell |
2022-11-28 | Herabstufung | Jefferies | Hold → Underperform |
2022-11-17 | Hochstufung | UBS | Neutral → Buy |
2022-10-28 | Herabstufung | Citigroup | Buy → Sell |
2022-08-24 | Herabstufung | Barclays | Overweight → Equal Weight |
2022-08-03 | Herabstufung | Macquarie | Outperform → Neutral |
2022-07-01 | Herabstufung | Nomura | Buy → Neutral |
2022-05-25 | Eingeleitet | Macquarie | Outperform |
2022-04-01 | Eingeleitet | HSBC Securities | Buy |
2022-03-24 | Eingeleitet | China Renaissance | Buy |
2022-03-23 | Eingeleitet | CLSA | Buy |
2022-02-08 | Eingeleitet | Barclays | Overweight |
2022-01-12 | Eingeleitet | Macquarie | Outperform |
2021-10-28 | Eingeleitet | Bernstein | Outperform |
2021-05-26 | Eingeleitet | Nomura | Buy |
2021-03-09 | Hochstufung | Daiwa Securities | Sell → Buy |
2021-01-29 | Eingeleitet | Morgan Stanley | Overweight |
2021-01-19 | Eingeleitet | Jefferies | Hold |
2020-12-14 | Eingeleitet | Deutsche Bank | Buy |
2020-12-03 | Herabstufung | UBS | Buy → Neutral |
2020-11-04 | Eingeleitet | Citigroup | Buy |
2020-09-25 | Eingeleitet | UBS | Buy |
2020-09-22 | Eingeleitet | JP Morgan | Overweight |
2020-09-21 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Xpeng Inc Adr Aktie (XPEV) Neueste Nachrichten
Brokerages Set XPeng Inc. Sponsored ADR (NYSE:XPEV) PT at $23.85 - MarketBeat
XPeng ADR Falls 8.89% Despite CEO's Increased Stake and Analyst Buy Ratings - AInvest
Invesco Ltd. Sells 211,904 Shares of XPeng Inc. Sponsored ADR $XPEV - MarketBeat
Quantbot Technologies LP Boosts Stake in XPeng Inc. Sponsored ADR $XPEV - MarketBeat
41,341 Shares in XPeng Inc. Sponsored ADR $XPEV Purchased by Quantitative Investment Management LLC - MarketBeat
XPeng, Inc. ADR Faces Stock Setback Amid Growth Plans - MSN
XPeng Inc. Sponsored ADR $XPEV Shares Sold by Jump Financial LLC - MarketBeat
XPeng Stock Falls 4.06% as 439th-Ranked U.S. Volume Highlights Mixed Analyst Sentiment and Strategic Moves - AInvest
This Chinese $30K Tesla Model 3 Rival Secured 10,000 Orders In Seven Minutes - Benzinga
XPEV Stock Shows Unexpected Upsurge - StocksToTrade
XPeng, Inc. ADR Soars: CEO’s Bold Move Boosts Stock - MSN
NIO, Xpeng among Tuesday’s market cap stock movers By Investing.com - Investing.com Canada
NIO, Xpeng among Tuesday’s market cap stock movers - Investing.com
What's Going On With Xpeng Shares Tuesday? - Benzinga
XPeng, Inc. ADR: Soaring Stock and Stellar Growth - MSN
Finanzdaten der Xpeng Inc Adr-Aktie (XPEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):